Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromes (Q28165924)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 2003)

Language	Label	Description	Also known as
English	Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromes	scientific article (publication date: 2003)

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

Europe PubMed Central

Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

acute coronary syndrome

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Nick Bosanquet

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

Bengt Jönsson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

1135-1152

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14863436 AND SRC:MED&resulttype=core&format=json

20 December 2019

Cost-efficacy in interventional cardiology; results from the EPISTENT study. Evaluation of Platelet IIb/IIIa Inhibitor For Stenting Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Even

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-Molecular-Weight Heparins

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs and effects of combining stenting and abciximab (ReoPro) in daily practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome wit

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactivation of unstable angina after the discontinuation of heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs and effects of c7E3 in high risk PTCA patients. An indirect analysis for The Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tiro

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of enoxaparin sodium versus heparin in unstable angina. A French sub-study of the ESSENCE trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical evidence of platelet activation in patients with persistent unstable angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coron

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-molecular-weight heparin : A review of the results of recent studies of the treatment of venous thromboembolism and unstable angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aspirin, heparin, or both to treat acute unstable angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycoprotein IIb/IIIa receptor therapy in percutaneous coronary intervention and non-ST-segment elevation acute coronary syndromes. Estimating the economic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes. A Canadian hospital perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14863436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28165924&oldid=2177488458"